Novel Drug Tested Against Hepatitis C

An experimental drug may one day help to treat hepatitis C, according to the results of a small study. The study included 36 people with hepatitis C. They were randomly assigned to five weekly injections of the drug miravirsen, or placebo. Three doses of miravirsen were tested. The drug reduced the amount of hepatitis C virus in people’s blood. Higher doses caused greater reductions. The effects lasted for several months. There were no signs of drug resistance. Miravirsen is a new type of drug, called an RNA interference drug. The study was published in the New England Journal of Medicine. National Public Radio wrote about it online.